Abstract:The here reported toxicity data are promising and encouraging in regard to the adoption of moderate hypofractionation with VMAT-SIB techniques, when cetuximab is concomitantly administered.
“…Alongi et al reported 9% of grade 1, 36% of grade 2 and 45% of grade 3 mucositis in a series of 22 elderly and chemotherapy-ineligible patients treated with radiotherapy plus cetuximab [14]. The results obtained in our pilot study are similar, as 60% of patients had grade 1 to 2 mucositis, and 40% of patients had grade 3 to 4 mucositis.…”
“…Alongi et al reported 9% of grade 1, 36% of grade 2 and 45% of grade 3 mucositis in a series of 22 elderly and chemotherapy-ineligible patients treated with radiotherapy plus cetuximab [14]. The results obtained in our pilot study are similar, as 60% of patients had grade 1 to 2 mucositis, and 40% of patients had grade 3 to 4 mucositis.…”
“…9 In the era of dose painting intensity-modulated radiation therapy, it becomes crucial to spare healthy structures to improve the patient's quality of life. Volumetric modulated arc therapy (VMAT) has been evaluated for patients with head and neck cancer [10][11][12][13][14] showing that it is a fast, safe, and accurate technique.…”
“…3 Intensity-modulated radiation therapy (IMRT) and rotational intensity-modulated techniques, including volumetricmodulated arc therapy (VMAT), allow for a better dose conformation to target structures while reducing the dose. [4][5][6][7][8] In comparison with three-dimensional-conformal radiation therapy, several studies have shown that IMRT in HNC treatment reduces overall adverse effects such as xerostomia and dysphagia and thus improves QoL, even when chemotherapy is added. [9][10][11][12][13] Regarding tolerance of the parotid glands, several studies have suggested significant recovery when the mean dose is inferior to 26 Gy.…”
We used recent guidelines to define dose constraints of the PCs and CM. Two results emerge in the present analysis: the superior PC influences late dysphagia, while the middle PC influences acute dysphagia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.